Telix participates in UBS Global Biopharma Conference

TLX•2026-11-11

Telix Pharmaceuticals will participate in the UBS Global Biopharma Conference in London on Nov. 17, 2026, with two executives joining a live webcast fireside chat.

1. Conference appearance

Telix Pharmaceuticals Group CEO Christian Behrenbruch and Therapeutics CEO Richard Valeix will join a fireside chat at 9:20 a.m. GMT, webcast live.

Sources

Telix participates in UBS Global Biopharma Conference

Publicnow

Telix participates in UBS Global Biopharma Conference

1. Conference appearance

Related News

CIBC raises iA Financial target price to C$225 from C$220

KKR forms 50:50 joint venture with RWE for UK offshore wind projects

North Sea gas maintenance schedule adds Atwick outage

Sources

Telix participates in UBS Global Biopharma Conference

Goldman Sachs expects 25 bp Fed hikes in December and March 2027, versus prior forecast for December only

Gold rebounds after sharp selloff though Fed hike bets weigh